New Insights in Vascular Development: Vasculogenesis and Endothelial Progenitor Cells

Abstract

In the course of new blood vessel formation, two different processes--vasculogenesis and angiogenesis--have to be distinguished. The term vasculogenesis describes the de novo emergence of a vascular network by endothelial progenitors, whereas angiogenesis corresponds to the generation of vessels by sprouting from pre-existing capillaries. Until recently, it was thought that vasculogenesis is restricted to the prenatal period. During the last decade, one of the most fascinating innovations in the field of vascular biology was the discovery of endothelial progenitor cells and vasculogenesis in the adult. This review aims at introducing the concept of adult vasculogenesis and discusses the efforts to identify and characterize adult endothelial progenitors. The different sources of adult endothelial progenitors like haematopoietic stem cells, myeloid cells, multipotent progenitors of the bone marrow, side population cells and tissue-residing pluripotent stem cells are considered. Moreover, a survey of cellular and molecular control mechanisms of vasculogenesis is presented. Recent advances in research on endothelial progenitors exert a strong impact on many different disciplines and provide the knowledge for functional concepts in basic fields like anatomy, histology as well as embryology.

Endothelial Nitric Oxide Synthase as A Marker for Human Endothelial Progenitor Cells

“…Importantly, the stable expression of eNOS and the ability to produce NO were observed in both types of EPCs. The term endothelial progenitor cell describes a group of cells existing in diverse stages of differentiation ranging from hemangioblasts to differentiated endothelial cells (Kassmeyer et al 2009). However, conflicting results have been reported in the field, and the identification and characterization of EPCs in vascular biology is still a subject of much discussion.…”

18F-FPPRGD2 and 18F-FDG PET of Response to Abraxane Therapy

“…One of the most important members of this receptor class is integrin a v b 3 , which is preferentially expressed on several types of cancer cells, including melanoma, glioma, and ovarian and breast cancers (14). Integrin a v b 3 is also expressed on proliferating endothelial cells associated with neovascularization in both malignant tumors and normal tissue but not in quiescent blood vessels (15,16).…”

The VEGF Pathway in Cancer and Disease: Responses, Resistance, and the Path Forward

“…Initially thought to be the induction of a cytokine that induces endothelial cell proliferation and new blood vessel development, we now have a more detailed understanding of vasculogenesis (the formation of de novo endothelial cell precursors needed to initiate neovascularization) and angiogenesis (the stimulation of neovascularizaton from existing vessels) (Semenza 2007;Kassmeyer et al 2009;Ribatti et al 2009). Although this is not completely accurate, we will use "angiogenesis" and "antiangiogenesis" to refer to the process of neovascularization and its inhibition, even if the target is directed more toward vasculogenesis.…”